Nonprofit · EIN 04-2531031
CANCER RESEARCH AMERICA NFCR INC
Tax-exempt · ROCKVILLE, MD 20852
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $11,095,696 | $9,799,090 | $1,296,606 | $12,279,522 | $3,006,290 | $9,273,232 |
| December 31, 2023 | 990 | $9,162,442 | $9,790,531 | -$628,089 | $10,533,674 | $2,852,963 | $7,680,711 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $10,388,208
- Program service revenue
- $0
- Investment income
- $691,486
- Royalties
- $826
- Net gain from sales of assets
- $399,389
- Net income from fundraising events
- -$20,992
- Other revenue
- $16,002
Expenses
- Grants and similar amounts paid
- $3,614,953
- Compensation of officers, directors and key employees
- $825,987
- Other salaries and wages
- $953,675
- Salaries, compensation and benefits (total)
- $2,009,945
- Professional fundraising fees
- $29,984
- Legal fees
- $19,500
- Accounting fees
- $54,833
- Occupancy
- $236,951
- Travel
- $27,231
- Depreciation
- $7,022
- Program services (functional)
- $7,278,495
- Management and general (functional)
- $714,283
- Fundraising (functional)
- $1,806,312
Balance sheet and other
- Total assets, start of year
- $10,533,674
- Total assets, end of year
- $12,279,522
- Total liabilities, end of year
- $3,006,290
- Net assets, end of year
- $9,273,232
- Land, buildings and equipment
- $17,518
- Publicly traded securities
- $6,479,022
- Net assets without donor restrictions
- $5,659,360
- Net assets with donor restrictions
- $3,613,872
- Gross receipts
- $11,230,864
- Employees
- 16
- Volunteers
- 70
- Year formed
- 1973
- State of legal domicile
- MA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| SUJUAN BA | PRESIDENT/CEO Officer | 40 | $462,395 | $94,834 |
| KWOK LEUNG | CFO/SECRETARY Officer | 40 | $231,444 | $33,999 |
| BRIAN WACHTEL | CHIEF DEV OFFICER/EXEC. DIR Highest-paid employee | 40 | $166,208 | $22,547 |
| ZETING WANG | SENIOR DIR OF DIRECT RESPONSE Highest-paid employee | 40 | $123,693 | $12,406 |
| ALFRED SLANETZ | CHAIR OF THE BOARD Trustee or director, Officer | 5 | $0 | $0 |
| BRIAN LEYLAND-JONES | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| JUDITH P BARNHARD | DIRECTOR Trustee or director | 1.5 | $0 | $0 |
| KAREN BURKE | DIRECTOR Trustee or director | 1 | $0 | $0 |
| FRANKLIN SALISBURY JR | DIRECTOR (EFF 01/31/2024) Trustee or director | 1 | $0 | $0 |
| SILAS DEANE | DIRECTOR (EFF 05/24/2024) Trustee or director | 1 | $0 | $0 |
| PADMAKUMAR KAIMAL | DIRECTOR (EFF 05/24/2024) Trustee or director | 1 | $0 | $0 |
| LANCE KAWAGUCHI | DIRECTOR (THRU 01/26/2024) Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 10 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| SUJUAN BA | PRESIDENT/CEO Officer | 40 | $471,385 | $81,925 |
| KWOK LEUNG | CFO/SECRETARY Officer | 40 | $204,079 | $30,434 |
| BRIAN WACHTEL | EXECUTIVE DIRECTOR Highest-paid employee | 40 | $151,108 | $17,381 |
| ZETING WANG | SR. DIR OF DIRECT RESPONSE Highest-paid employee | 40 | $124,087 | $11,940 |
| ALFRED SLANETZ | CHAIR OF THE BOARD Trustee or director, Officer | 5 | $0 | $0 |
| BRIAN LEYLAND-JONES | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| JUDITH P BARNHARD | DIRECTOR Trustee or director | 1.5 | $0 | $0 |
| KAREN BURKE | DIRECTOR Trustee or director | 1.5 | $0 | $0 |
| LANCE KAWAGUCHI | DIRECTOR Trustee or director | 1 | $0 | $0 |
| Edward s west | Director (THRU 04/26/2023) Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 5515 SECURITY LN STE 1105, ROCKVILLE, MD 20852-5018
- In care of
- % KWOK LEUNG
- Principal officer (990 for 2024)
- SUJUAN BA, 5515 SECURITY LANE SUITE 1105, Rockville, MD 20852
- Signed the 990
- SUJUAN BA, PRESIDENT & CEO
- Phone
- (301) 654-1250
- Website
- WWW.NFCR.ORG
- Return prepared by
- WITHUMSMITHBROWNPC
Mission
SEE SCHEDULE O
Program accomplishments
- Scientific Advancement: In 2023-2024, NFCR funded 37 scientists conducting groundbreaking research across more than 15 cancer types. This investment fuels basic, translational, and clinical research, expanding the global knowledge base and accelerating new therapeutic approaches. Clinical Impact: NFCR-supported discoveries advanced 7 therapies into clinical trial phases (5 Phase 1, 2 Phase 2), bringing innovative treatments closer to patients in need. Innovation Translation: NFCR contributed to breakthroughs in liquid biopsy technologies for early detection and precision oncology approaches, supporting innovations that improve patient outcomes and inform prevention strategies. Public Health Outreach: In 2024, NFCR distributed over 250 Cancer Prevention Kits, directly reaching over 1000 individuals through about 100 community events nationwide. These resources empower the public to adopt cancer-preventive behaviors and pursue timely screenings. Marketing & Communications Impact: NFCR's marketing and communications strategies amplify the reach, engagement, and influence of our scientific funding and public health initiatives, ensuring that program results translate into broad awareness, donor action, and sustained mission support. Owned & social channels: NFCR runs an active content ecosystem, including a blog, and media gallery with two YouTube series (Making Sense of Science and Cancer-Fighting Lifestyle), the All Things CANCER podcast, and an email newsletter sign-up for ongoing education and donor stewardship. Public education assets: NFCR publishes accessible prevention resources, including the downloadable Cancer Prevention & Early Detection Kit and Cancer Screening Guidelines, which reinforce behavior change and early detection messaging. Thought leadership & convenings: The annual NFCR Global Summit & Award Ceremonies serve as a collaboration engine where "new partnerships form every year," expanding the impact of NFCR's science communications beyond owned channels. Fundraising communications tied to outcomes: Event communications (e.g., Daffodils & Diamonds) publicly report results linking storytelling to tangible support for research. Mission context for all outreach: NFCR consistently communicates scale and stewardship - $420M+ funded and 5.3M+ lifetime donors in progress/annual reports and "About" materials, anchoring all marketing in mission impact. Through global collaboration, NFCR is making unique impact on a new and accelerated path to cures. NFCR envisions a world without cancer!Expenses $5,045,821 · grants $3,614,953
- NFCR provides the public with free materials containing valuable information on the most up-to-date cancer preventive measures, treatment options, and diagnostic tools. Our powerful message has been mailed annually to households, reaching over 235,000 email subscribers and tens of thousands of individuals through our social media channels (Twitter and Facebook) and through our website and blogs, helps to assure that fewer of today's healthy individuals will get cancer and more of today's cancer patients will become tomorrow's cancer survivors. Our public education materials include early cancer detection guide, cancer prevention kits, recipes for healthy living, electronic and printed newsletters, the latest cancer headlines, and in-depth online cancer information.Expenses $2,232,674
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 04-2531031
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Group exemption
- Exempt since
- 2010
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H30)
- Group exemption
- 5582 (1 member organizations)
- Assets (IRS master file)
- $12,279,522
- Income (IRS master file)
- $11,230,864
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $11,095,696 | $9,799,090 | $12,279,522 | IRS |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $9,162,442 | $9,790,531 | $10,533,674 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $8,408,059 | $8,484,908 | $10,719,078 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 04-2531031).
Questions about CANCER RESEARCH AMERICA NFCR INC
- What is the EIN of CANCER RESEARCH AMERICA NFCR INC?
- The employer identification number (EIN) of CANCER RESEARCH AMERICA NFCR INC is 04-2531031.
- Is CANCER RESEARCH AMERICA NFCR INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2010.
- Are donations to CANCER RESEARCH AMERICA NFCR INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Group exemption).
- Which annual return does CANCER RESEARCH AMERICA NFCR INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of CANCER RESEARCH AMERICA NFCR INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CANCER RESEARCH AMERICA NFCR INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of CANCER RESEARCH AMERICA NFCR INC?
- The 990 for the year ended December 31, 2024 names SUJUAN BA.
- Who are the officers and directors of CANCER RESEARCH AMERICA NFCR INC?
- The 990 for the year ended December 31, 2024 lists 12 people; 4 received compensation from the organization, the highest $462,395 (SUJUAN BA, PRESIDENT/CEO).
- How much revenue does CANCER RESEARCH AMERICA NFCR INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $11,095,696, expenses of $9,799,090 and total assets of $12,279,522 at year end.
Organizations in its group exemption (1)
- NATIONAL FOUNDATION FOR CANCER RESEARCH INC EIN 27-4528107 · ROCKVILLE, MD · last filed 990-N for 2023
Other nonprofits in ROCKVILLE
- FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC EIN 52-1986675 · last filed 990 for 2024
- AMERICAN COLLEGE OF GASTROENTEROLOGY INC EIN 13-1883814 · last filed 990 for 2024
- HEART FAILURE SOCIETY OF AMERICA INC EIN 06-1416238 · last filed 990 for 2025
- AOAC INTERNATIONAL EIN 53-0029357 · last filed 990 for 2025
- THE STANLEY MEDICAL RESEARCH INSTITUTE EIN 06-1610506 · last filed 990 for 2024
- BIOHEALTH INNOVATION INC EIN 45-3824067 · last filed 990 for 2024
- AMERICAN SPEECH-LANGUAGE-HEARING FOUNDATION EIN 52-6055761 · last filed 990 for 2024
- AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY INC EIN 94-6079945 · last filed 990 for 2024